Lab
CMT Group, Corp
CMT Group, Corp was paid $2.34M by Medicaid between Jan 2018 and Oct 2024, across 66 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 17% of everything it billed.
33Billing provider infoCMT GROUP, CORP
SAN JUAN, PR 00927
SAN JUAN, PR 00927
33aNPI1053735431assigned 02/06/2014
33bProvider typeClinical Medical Laboratory
28Total paid$2.34M
24GClaims184,787
24DCodes billed66
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#36 of 777
Median peer was paid$278K
This provider vs. median8.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,647 | $230K | |
| 2019 | 27,415 | $281K | |
| 2020 | 33,037 | $415K | |
| 2021 | 40,882 | $632K | |
| 2022 | 25,035 | $375K | |
| 2023 | 17,611 | $209K | |
| 2024incomplete | 16,160 | $202K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17% | 10,165 | 9,231 | $389K |
| 84443 | Thyroid stimulating hormone (TSH) | 10% | 14,723 | 14,160 | $244K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9.0% | 11,331 | 10,188 | $211K |
| 80061 | Lipid panel | 8.9% | 15,437 | 14,932 | $209K |
| 80053 | Comprehensive metabolic panel | 7.0% | 15,552 | 14,936 | $164K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.8% | 21,249 | 20,327 | $159K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.6% | 10,974 | 10,648 | $107K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.2% | 3,956 | 3,799 | $99K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.3% | 1,859 | 1,724 | $77K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.6% | 1,726 | 1,672 | $62K |
| 81001 | 2.6% | 19,492 | 18,659 | $61K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.4% | 1,578 | 1,527 | $56K |
54 more codes
| 86328 | 2.4% | 3,955 | $56K | |
| 84436 | 2.0% | 7,177 | $48K | |
| 84153 | 1.8% | 2,425 | $43K | |
| 82274 | 1.7% | 2,584 | $40K | |
| 82043 | 1.5% | 6,364 | $36K | |
| 84439 | 1.2% | 3,103 | $28K | |
| 80074 | <1% | 522 | $23K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,027 | $23K |
| 86803 | <1% | 1,593 | $22K | |
| 86701 | <1% | 2,426 | $21K | |
| 87088 | <1% | 2,458 | $21K | |
| 80069 | <1% | 2,005 | $15K | |
| 87400 | <1% | 1,011 | $15K | |
| 82607 | <1% | 851 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,356 | $11K |
| 86738 | <1% | 778 | $9K | |
| 84479 | <1% | 1,446 | $8K | |
| 83655 | <1% | 643 | $8K | |
| 83970 | <1% | 166 | $7K | |
| 82570 | <1% | 1,307 | $7K | |
| 86703 | <1% | 544 | $6K | |
| 86592 | <1% | 1,542 | $6K | |
| 85730 | <1% | 709 | $4K | |
| 82270 | <1% | 1,135 | $4K | |
| 85651 | <1% | 958 | $3K | |
| 86696 | <1% | 162 | $3K | |
| 85610 | <1% | 804 | $3K | |
| 84156 | <1% | 746 | $2K | |
| 87177 | <1% | 431 | $2K | |
| 86695 | <1% | 159 | $2K | |
| 82950 | <1% | 468 | $2K | |
| 84550 | <1% | 480 | $2K | |
| 86140 | <1% | 311 | $2K | |
| 83540 | <1% | 222 | $1K | |
| 84481 | <1% | 74 | $1K | |
| 82951 | <1% | 102 | $1K | |
| 86038 | <1% | 98 | $1K | |
| 86706 | <1% | 75 | $818.66 | |
| 84100 | <1% | 87 | $329.42 | |
| 84300 | <1% | 59 | $306.74 | |
| 82947 | <1% | 82 | $306.58 | |
| 83001 | <1% | 19 | $303.75 | |
| 86708 | <1% | 16 | $207.60 | |
| 86709 | <1% | 17 | $193.30 | |
| 82746 | <1% | 12 | $192.24 | |
| 87899 | <1% | 67 | $174.15 | |
| 83550 | <1% | 18 | $142.95 | |
| 82952 | <1% | 28 | $129.93 | |
| 83735 | <1% | 20 | $128.19 | |
| 85044 | <1% | 29 | $126.95 | |
| 80076 | <1% | 13 | $110.45 | |
| 82044 | <1% | 31 | $101.85 | |
| 86431 | <1% | 15 | $89.66 | |
| 86430 | <1% | 15 | $80.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENGOCHEA DE ACEVEDO, INGRID (EXCECUTIVE VP AND CFO)